FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers

Oct 8, 2024
FDA guidance

In October 2024, the U.S. Food and Drug Administration issued a final guidance titled Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers. https://www.fda.gov/media/166215/download  

 
This guidance provides recommendations on the use of electronic systems, electronic records and electronic signatures in food, medical product, tobacco product, and new animal drug clinical investigations. 

This guidance finalizes the draft guidance for industry issued in March 2023, titled Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11–Questions and Answers.  

Flex Databases has analyzed the guidance and is ready to share how we support our Clients being the trusted software development vendor. 

Regulated entities are responsible for ensuring that electronic records meet applicable part 11 requirements. When determining the suitability of the IT service and IT service provider, regulated entities should consider the following regarding the IT service provider’s ability to ensure the authenticity, integrity, and confidentiality of clinical investigation records and data:  

FDA requirement Flex Databases guarantees 
Processes and procedures the IT service provider has in place for validation of specific IT services to be used in the clinical investigation  Fully validated system with the validation deliverables package Support during User Acceptance Testing 
Ability of the IT service provider to generate accurate and complete copies of records and to provide access to data for as long as the records are required to be retained by applicable regulations  Retention period is negotiated and captured in the contract. All the data stored in the system is subject to full backup and is stored as long as required. 
Processes and procedures the IT service provider has for data migration, data backup, recovery, contingency plans, and retaining records and making them available for FDA inspection for as long as the records are required to be retained by applicable regulations Always ready to share our SOPs, including the backup procedure, Disaster Recovery and Business Continuity Plans and Reports, data migration working practice and relevant deliverables  
Ability to provide secure, computer-generated, time-stamped audit trails of users’ actions and changes to data Audit trail captures all actions performed in the system 
Ability to secure and protect the confidentiality of data at rest and in transit (as appropriate for the content and nature of the record) All traffic into and out of the Flex Databases Platform is encrypted, all backups are encrypted-in-transit to the separate data center and are encrypted-at-rest while stored at that location. 

Blog

user meetup
October User Group Meeting Recap: New eTMF Features, Client Feedback, and Future Plans

A new round of our traditional meetings took place in October. This time, we gathered our beloved users to discuss the use of eTMF — from everyday activities to audit preparation. We reviewed how newly released features, such as duplicate search, quality review, and metadata notifications, influence TMF workflows. It appeared not everyone was using […]

Learn more
OCT BIO 2024
Meet us at BIO-Europe!

We’re excited to announce that Flex Databases will be participating in this prestigious event from November 4–6, 2024. Join us to explore our innovative solutions! Connect with Kristina Kojoushko at the event to learn more about our services, including eTMF, CTMS, Pharmacovigilance Software and more. 📅 Schedule a meeting with Kristina at kristina.kojoushko@flexdatabases.com or reach […]

Learn more
Webinar with deloitte
Webinar Recording: Quality Digitalization with Deloitte

Did you miss our recent webinar on Quality Digitalization? The recording is now available! In this insightful session, Anna Petrovskaya, QA Director at Flex Databases, and Vera Valesova, PhD, Senior Manager at Deloitte, explore the critical aspects of transforming your QMS into a digital solution. Key topics covered: Watch the full webinar and gain valuable […]

Learn more
Testimony Agenus
Why Agenus Chose Flex Databases: A Client’s Perspective

October, 2024 – Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a strong pipeline of immune modulating antibodies, together with Flex Databases announce the successful implementation of Flex Databases’ Clinical Trial Management System (CTMS) and electronic Trial Master File (eTMF) solutions, including a new AI-driven feature for automated document filing and metadata assignment. This partnership […]

Learn more

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.